KalVista Pharmaceuticals, Inc. today announced new data from its sebetralstat clinical trial program presented at the 2026 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results